Improved Fecal DNA Test for Colorectal Cancer Screening

Slides:



Advertisements
Similar presentations
MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Volume 135, Issue 2, Pages e7 (August 2008)
Hongzhi Zou, Jonathan J. Harrington, Aravind Sugumar, Kristie K
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Neal K. Osborn, Hongzhi Zou, Julian R
Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany  Hermann Brenner, Lutz Altenhofen,
Celiac Disease and Persistent Symptoms
Katsunori Matsueda, Tatsuya Toyokawa 
When Should We Suspect Hereditary Colorectal Cancer Syndrome?
David L. McCollum, J. Martin Rodriguez 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Volume 152, Issue 6, Pages (May 2017)
Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Guro E. Lind, Terje Ahlquist, Ragnhild A. Lothe  Gastroenterology 
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Should the Reflex Be Reflux
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Granular Cell Tumor in Colonic Polyp Found on Screening Colonoscopy
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Miles Basil, Anita Pudusseri, Robert Lowe 
Eighty-Year-Old Patient With History of a Twelve Millimeter Adenomatous Polyp Resected at Age of Seventy-Five Years  David Lieberman  Clinical Gastroenterology.
Bisphosphonates Are Associated With Reduced Risk of Colorectal Cancer: A Systematic Review and Meta-analysis  Siddharth Singh, Abha Goyal Singh, Mohammad.
Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A
When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?  Folasade P. May, Samir Gupta  Clinical Gastroenterology.
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Features and Outcomes of Patients With Ischemia Isolated to the Right Side of the Colon When Accompanied or Followed by Acute Mesenteric Ischemia  Paul.
DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease  Mansour.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Hongzhi Zou, Jonathan J. Harrington, Aravind Sugumar, Kristie K
New Models of Gastroenterology Practice
Improved Diagnosis of Colorectal Cancer Using a Combination of Fecal Occult Blood and Novel Fecal Protein Markers  Johann Karl, Norbert Wild, Michael.
Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer  Shari S. Rogal, Paul F. Pinsky, Robert E.
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
David H. Bruining, William J. Sandborn 
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Deborah A. Fisher, Joseph Galanko, Tara K. Dudley, Nicholas J. Shaheen 
Mantle Cell Lymphoma Presenting as Colonic Lymphomatous Polyposis
Colonoscopy Identifies Increased Prevalence of Large Polyps or Tumors in Patients 40– 49 Years Old With Hematochezia vs Other Gastrointestinal Indications 
Colorectal Cancer Screening: How to Stop a Moving Target
A Program to Enhance Completion of Screening Colonoscopy Among Urban Minorities  Lea Ann Chen, Stephanie Santos, Lina Jandorf, Jennifer Christie, Anabella.
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Heiko Pohl, Douglas J. Robertson 
Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis  Stephen P. Nguyen, Stephen Bent, Yea-Hung.
Alan Bonder, MD, Nezam H. Afdhal, MD 
Volume 132, Issue 1, Pages (January 2007)
John Scott Maul, Randall W. Burt, Lisa A. Cannon–Albright 
Thrombocytopenia With Abnormal Liver Function Tests
Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Familial Colorectal Cancer, Beyond Lynch Syndrome
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Volume 138, Issue 6, Pages (May 2010)
Black and White Liver Clinical Gastroenterology and Hepatology
Adverse Outcomes: Why Bad Things Happen to Good People
Clinical Gastroenterology and Hepatology
Konstanze Lenhard, Guido T
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Issue Highlights Clinical Gastroenterology and Hepatology
Detection of Serrated Lesions: We Are Still in the Teething Stage
The Role of Psychosocial Care in Adapting to Health Care Reform
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Improved Fecal DNA Test for Colorectal Cancer Screening Steven H. Itzkowitz, Lina Jandorf, Randall Brand, Linda Rabeneck, Paul C. Schroy, Stephen Sontag, David Johnson, Joel Skoletsky, Kris Durkee, Sanford Markowitz, Anthony Shuber  Clinical Gastroenterology and Hepatology  Volume 5, Issue 1, Pages 111-117 (January 2007) DOI: 10.1016/j.cgh.2006.10.006 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Detection of vimentin methylation in fecal DNA analyzed by VIM-29 PCR primers. Amplification of fecal DNA from 9 normal (n) and 5 colon cancer (c) patients. Upper panel (VIM-29M) shows vimentin gene methylation and the lower panel (VIM-29U) shows control wild-type amplification of unmethylated vimentin sequences derived from normal cells in all samples. Positive (+) vimentin methylation is noted next to the sample identification number. Assay controls include unmethylated (u) and methylated (m) DNA samples, and negative water blank (deionized water). Clinical Gastroenterology and Hepatology 2007 5, 111-117DOI: (10.1016/j.cgh.2006.10.006) Copyright © 2007 AGA Institute Terms and Conditions